SAN DIEGO--(BUSINESS WIRE)--Aethlon Medical, Inc. (OTCBB:AEMD) disclosed this evening that its CEO, James A. Joyce, is currently featured in an on-line interview with CEOcast, Inc. During the interview, Mr. Joyce discusses the “first-in-man” clinical study of the Aethlon Hemopurifier® as a treatment for HIV/AIDS. The Hemopurifier®, which provides real-time therapeutic filtration of infectious viruses and immunosuppressive proteins, holds promise to extend the lives of AIDS patients by removing HIV strains that cause drug failure and reducing the presence of viral proteins that kill-off immune cells. The interview is now available to be accessed through a free registration at http://www.ceocast.com.
